{
  "exportMetadata": {
    "version": "1.0.0",
    "exportedAt": 1704412800000,
    "exportedBy": "AI Template Generator",
    "applicationVersion": "1.0.0",
    "description": "Example cardiovascular RCT template - Ready for AI to fill",
    "totalProjects": 1,
    "totalProtocols": 1,
    "totalManuscripts": 1,
    "totalClinicalRecords": 300
  },
  "projects": [
    {
      "project": {
        "id": "project-cardio-rct-001",
        "name": "ACE-X Hypertension Trial",
        "description": "Phase III randomized controlled trial evaluating efficacy and safety of novel ACE inhibitor ACE-X versus placebo in essential hypertension",
        "studyDesign": "RCT",
        "createdAt": 1704412800000,
        "settings": {
          "primaryInvestigator": "Dr. [AI TO FILL]",
          "institution": "[AI TO FILL]",
          "phase": "Phase III",
          "therapeuticArea": "Cardiology - Hypertension",
          "patientCount": 300,
          "enrollmentStart": "[AI TO FILL: ISO DATE]",
          "enrollmentEnd": "[AI TO FILL: ISO DATE]",
          "followUpDuration": "12 months",
          "primaryEndpoint": "Mean change in sitting systolic blood pressure from baseline to 12 months",
          "secondaryEndpoints": [
            "Mean change in diastolic blood pressure",
            "Proportion achieving BP control (<140/90 mmHg)",
            "Major adverse cardiovascular events (MACE)",
            "All-cause mortality",
            "Quality of life (SF-36 score)"
          ],
          "inclusionCriteria": [
            "Age 45-75 years",
            "Essential hypertension (SBP 140-180 mmHg)",
            "No BP medications for ≥4 weeks",
            "eGFR >60 mL/min/1.73m²",
            "Willing to provide informed consent"
          ],
          "exclusionCriteria": [
            "Secondary hypertension",
            "Recent cardiovascular event (<6 months)",
            "NYHA Class III-IV heart failure",
            "Severe renal impairment (eGFR <45)",
            "Known ACE inhibitor allergy",
            "Pregnancy or lactation"
          ],
          "statisticalPower": 0.9,
          "alphaLevel": 0.05,
          "randomizationRatio": "1:1",
          "blindingStrategy": "double-blind",
          "interventions": [
            {
              "name": "ACE-X",
              "type": "drug",
              "dosage": "10mg",
              "frequency": "Once daily",
              "duration": "12 months"
            },
            {
              "name": "Placebo",
              "type": "drug",
              "dosage": "Matching tablet",
              "frequency": "Once daily",
              "duration": "12 months"
            }
          ]
        }
      },
      "protocols": [
        {
          "id": "protocol-001",
          "protocolNumber": "PROTO-2024-CARDIO-001",
          "protocolTitle": "Efficacy and Safety of ACE-X versus Placebo in Essential Hypertension",
          "versions": [
            {
              "id": "version-001",
              "versionNumber": "1.0.0",
              "status": "published",
              "createdAt": 1704412800000,
              "schemaBlocks": [
                {
                  "id": "demo_age",
                  "label": "Age",
                  "category": "demographics",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "years",
                  "minValue": 18,
                  "maxValue": 120,
                  "clinicalSignificance": "Age affects hypertension prevalence and treatment response",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "baseline",
                  "visitNumber": 1
                },
                {
                  "id": "demo_sex",
                  "label": "Sex",
                  "category": "demographics",
                  "dataType": "categorical",
                  "required": true,
                  "options": ["Male", "Female"],
                  "clinicalSignificance": "Sex differences in BP and cardiovascular risk",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "baseline",
                  "visitNumber": 1
                },
                {
                  "id": "demo_race",
                  "label": "Race/Ethnicity",
                  "category": "demographics",
                  "dataType": "categorical",
                  "required": true,
                  "options": ["White", "Black/African American", "Hispanic/Latino", "Asian", "Other"],
                  "clinicalSignificance": "Racial differences in hypertension prevalence and drug response",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "baseline",
                  "visitNumber": 1
                },
                {
                  "id": "vital_height",
                  "label": "Height",
                  "category": "vital-signs",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "cm",
                  "minValue": 140,
                  "maxValue": 210,
                  "clinicalSignificance": "Required for BMI calculation",
                  "collectionTimepoint": "baseline",
                  "visitNumber": 1
                },
                {
                  "id": "vital_weight",
                  "label": "Weight",
                  "category": "vital-signs",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "kg",
                  "minValue": 40,
                  "maxValue": 200,
                  "clinicalSignificance": "Weight affects cardiovascular risk",
                  "collectionTimepoint": "as-needed",
                  "visitNumber": null
                },
                {
                  "id": "vital_sbp",
                  "label": "Systolic Blood Pressure",
                  "category": "vital-signs",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "mmHg",
                  "minValue": 80,
                  "maxValue": 250,
                  "clinicalSignificance": "Primary endpoint variable",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "as-needed",
                  "visitNumber": null
                },
                {
                  "id": "vital_dbp",
                  "label": "Diastolic Blood Pressure",
                  "category": "vital-signs",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "mmHg",
                  "minValue": 40,
                  "maxValue": 150,
                  "clinicalSignificance": "Secondary endpoint variable",
                  "collectionTimepoint": "as-needed",
                  "visitNumber": null
                },
                {
                  "id": "vital_hr",
                  "label": "Heart Rate",
                  "category": "vital-signs",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "bpm",
                  "minValue": 40,
                  "maxValue": 180,
                  "clinicalSignificance": "Safety monitoring",
                  "collectionTimepoint": "as-needed",
                  "visitNumber": null
                },
                {
                  "id": "lab_creatinine",
                  "label": "Serum Creatinine",
                  "category": "laboratory",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "mg/dL",
                  "minValue": 0.3,
                  "maxValue": 15,
                  "clinicalSignificance": "Renal function monitoring (ACE inhibitor safety)",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "monthly",
                  "visitNumber": null
                },
                {
                  "id": "lab_potassium",
                  "label": "Serum Potassium",
                  "category": "laboratory",
                  "dataType": "continuous",
                  "required": true,
                  "unit": "mEq/L",
                  "minValue": 2.0,
                  "maxValue": 7.0,
                  "clinicalSignificance": "Hyperkalemia monitoring (ACE inhibitor side effect)",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "monthly",
                  "visitNumber": null
                },
                {
                  "id": "lab_glucose",
                  "label": "Fasting Glucose",
                  "category": "laboratory",
                  "dataType": "continuous",
                  "required": false,
                  "unit": "mg/dL",
                  "minValue": 50,
                  "maxValue": 500,
                  "clinicalSignificance": "Metabolic risk factor",
                  "collectionTimepoint": "baseline",
                  "visitNumber": 1
                },
                {
                  "id": "ae_type",
                  "label": "Adverse Event Type",
                  "category": "adverse-events",
                  "dataType": "categorical",
                  "required": false,
                  "options": [
                    "None",
                    "Dry cough",
                    "Dizziness",
                    "Headache",
                    "Fatigue",
                    "Hypotension",
                    "Hyperkalemia",
                    "Angioedema",
                    "Rash",
                    "Other"
                  ],
                  "clinicalSignificance": "Safety profile documentation",
                  "regulatoryRequirement": true,
                  "collectionTimepoint": "as-needed",
                  "visitNumber": null
                }
              ]
            }
          ],
          "currentVersion": "1.0.0"
        }
      ],
      "clinicalData": [
        {
          "recordId": "[AI TO GENERATE UNIQUE IDs FOR 300 RECORDS]",
          "subjectId": "[AI TO GENERATE: SUBJ-001 through SUBJ-300]",
          "visitDate": "[AI TO GENERATE: Spread across 12 months]",
          "visitNumber": "[1-5 for each patient]",
          "protocolNumber": "PROTO-2024-CARDIO-001",
          "protocolVersion": "1.0.0",
          "data": {
            "demo_age": "[AI: 45-75 years, mean ~60]",
            "demo_sex": "[AI: 55% Male, 45% Female]",
            "demo_race": "[AI: 60% White, 20% Black, 15% Hispanic, 5% Asian]",
            "vital_height": "[AI: 150-190 cm, realistic for sex]",
            "vital_weight": "[AI: BMI 25-35 kg/m²]",
            "vital_sbp": "[AI: Baseline 145-175, Treatment group -12±8 mmHg, Placebo -3±7 mmHg]",
            "vital_dbp": "[AI: Baseline 85-105, Treatment group -7±6 mmHg, Placebo -2±5 mmHg]",
            "vital_hr": "[AI: 60-90 bpm, slight variations]",
            "lab_creatinine": "[AI: 0.7-1.5 mg/dL baseline, monitor for increases]",
            "lab_potassium": "[AI: 3.5-5.0 mEq/L baseline, watch for hyperkalemia in treatment group]",
            "lab_glucose": "[AI: 85-125 mg/dL, some patients with pre-diabetes]",
            "ae_type": "[AI: Treatment arm: 15% cough, 12% dizziness, 8% headache, 7% fatigue, 4% hypotension; Placebo arm: lower rates]"
          },
          "enteredBy": "[AI TO FILL]",
          "enteredAt": "[AI TO FILL: Timestamp]",
          "status": "verified"
        }
      ],
      "manuscripts": [
        {
          "id": "manuscript-001",
          "projectMeta": {
            "projectId": "project-cardio-rct-001",
            "studyTitle": "ACE-X Hypertension Trial",
            "primaryInvestigator": "[AI TO FILL]",
            "protocolRef": "1.0.0",
            "createdAt": 1704412800000,
            "modifiedAt": 1704412800000
          },
          "manuscriptStructure": {
            "methods": {
              "statisticalPlan": {
                "software": "Clinical Intelligence Engine v1.0",
                "primaryTest": "Independent samples t-test for primary endpoint",
                "rationale": "Parallel group design with continuous outcome"
              },
              "populationSummary": "Adults aged 45-75 with essential hypertension"
            },
            "results": {
              "primaryFindings": [],
              "secondaryFindings": []
            },
            "discussionAnchors": {
              "internalConflicts": "",
              "lateralOpportunities": []
            }
          },
          "notebookContext": {
            "linkedSources": [
              {
                "id": "source-001",
                "title": "A Randomized Trial of Intensive versus Standard Blood-Pressure Control",
                "authors": ["SPRINT Research Group"],
                "year": 2015,
                "journal": "New England Journal of Medicine",
                "doi": "10.1056/NEJMoa1511939",
                "pmid": "26551272",
                "abstract": "[AI TO FILL: Real SPRINT trial abstract]",
                "keyFindings": [
                  "Intensive BP control (SBP <120) reduced CV events",
                  "Increased risk of hypotension and AKI",
                  "Benefits greatest in older patients"
                ],
                "citationKey": "SPRINT_2015",
                "enabled": true
              }
            ],
            "citationMap": {}
          },
          "manuscriptContent": {
            "introduction": "[AI TO GENERATE: 800 words covering burden of hypertension, current treatments, rationale for ACE-X, study objectives]",
            "methods": "[AI TO GENERATE: 1200 words covering study design, population, randomization, treatment protocols, outcome measures, statistical analysis]",
            "results": "[AI TO GENERATE: 1500 words covering patient disposition, baseline characteristics, primary endpoint (Treatment -12 mmHg vs Placebo -3 mmHg, p<0.001), secondary endpoints, subgroups, safety]",
            "discussion": "[AI TO GENERATE: 1200 words covering interpretation, comparison with other trials, clinical significance, limitations, implications]",
            "conclusion": "[AI TO GENERATE: 300 words summarizing key findings and clinical impact]"
          },
          "reviewComments": []
        }
      ],
      "statisticalManifests": [
        {
          "manifestMetadata": {
            "protocolId": "protocol-001",
            "protocolVersion": "1.0.0",
            "generatedAt": 1704412800000,
            "statistician": "[AI TO FILL]",
            "totalRecordsAnalyzed": 300
          },
          "descriptiveStats": [
            {
              "variableId": "demo_age",
              "label": "Age",
              "results": {
                "n": 300,
                "mean": "[AI: ~60]",
                "median": "[AI: ~61]",
                "stdDev": "[AI: ~8]",
                "min": "[AI: ~45]",
                "max": "[AI: ~75]",
                "q1": "[AI: ~54]",
                "q3": "[AI: ~66]",
                "missing": 0,
                "outliers": []
              }
            },
            {
              "variableId": "vital_sbp",
              "label": "Systolic BP Change",
              "results": {
                "n": 300,
                "mean": "[AI: Treatment -12, Placebo -3]",
                "stdDev": "[AI: Treatment 8, Placebo 7]",
                "missing": "[AI: 3-5 missing]"
              }
            }
          ],
          "comparativeAnalyses": [
            {
              "id": "primary-analysis-001",
              "testType": "ttest",
              "variable1": "vital_sbp_change",
              "groups": ["Treatment", "Placebo"],
              "testStatistic": "[AI TO CALCULATE]",
              "degreesOfFreedom": 298,
              "pValue": "[AI: <0.001]",
              "confidenceInterval": {
                "lower": "[AI: ~-11.2]",
                "upper": "[AI: ~-6.8]"
              },
              "effectSize": "[AI: Cohen's d ~1.2]",
              "interpretation": "Statistically significant reduction in SBP with ACE-X treatment",
              "clinicalSignificance": "9 mmHg difference exceeds clinically meaningful threshold of 5 mmHg"
            }
          ],
          "advancedModeling": []
        }
      ],
      "personas": [],
      "templates": []
    }
  ],
  "globalTemplates": [],
  "globalPersonas": []
}
